Wczytywanie kursów wyceny...

Prognoza

Kupuj
  4
Trzymaj
  1
Sprzedaj
  1

Dyskusje w społeczności

  • 2 19
  • 2 Jahre altes Portfolio (Angestellt, 22 Jahre alt)

    Luca S. Luca S. I w Portfolio Roasts

    7 2
  • Stefan kauft Aktien

    S Stefan V w Portfolio Roasts

    13 32
  • Meinung / Verbesserungsvorschläge

    J Justin IV w Portfolio Roasts

    0 7
  • Portfolio

    M0 Marie.mar 03 V w Portfolio Roasts

    6 23

  • Antitrust case against Brau Union (Heineken) referred to the European Court of Justice

    The antitrust proceedings by the Austrian Federal Competition Authority (BWB) against Brau Union, part of the Heineken group, over alleged abuse of market power have been referred to the European Court of Justice. The BWB accuses the group of pressuring beverage retailers to prioritise selling its products. Heineken denies the allegations and complains of insufficient access to the case files; if convicted the company could face a fine of up to ten percent of group turnover. An ECJ decision can take more than a year, and the ongoing proceedings before the Cartel Court in Vienna remain unaffected. » Więcej na kurier.at


  • Heineken beats expectations thanks to premium and non-alcoholic beer

    Heineken reports an organic volume increase of 4.8% in the third quarter and a sales rise of 4.6%, well above analysts' expectations of 2.9% and 3.5% respectively. The premium segment grew particularly strongly, by 11.5%; all regions contributed to the growth. New group CEO Rafa Oliveira is calling for a stronger performance culture and faster execution and plans to present details of his strategy in February. For the full year 2026, Heineken confirms its forecast of organic operating profit growth of 2% to 6%. » Więcej na n-tv.de


  • Heineken warns of sales risk in British pubs from weight-loss injections

    Heineken warns that GLP-1 weight-loss drugs such as Ozempic or Wegovy could reduce alcohol cravings through increased feelings of fullness, endangering beer and cider sales in British pubs. The company recommended measures for publicans such as smaller beer glasses, alcohol-free alternatives and food pairings to cushion revenue losses. U.S. market data show households with GLP-1 users have about 7% lower alcohol spending after two years and roughly 13.5% less spending on beer; other spirits companies so far assess the risk as manageable. » Więcej na manager-magazin.de


  • Heineken warns GLP-1 weight-loss drugs could dent UK beer and cider sales

    Heineken told UK pub and bar customers that the rise of GLP-1 drugs such as Wegovy and Ozempic can reduce desire to drink alcohol, leading to smaller serves and fewer pints per visit. The brewer advised promoting half-pints, low- and no-alcohol options and food pairings to mitigate potential declines in visits and spending. Heineken said it will monitor changing consumption patterns through 2027, while industry data on the impact remains mixed. » Więcej na theguardian.com


  • Heineken ordered to pay €111 million in damages, group announces appeal

    A Dutch court has ordered Heineken to pay €111 million in a dispute between its Greek subsidiary Athenian Brewery and rival Macedonian Thrace Brewery (€43m in damages plus €68m in interest). Heineken plans to appeal, saying the underlying assumptions on sales, pricing and profitability are unrealistic. The case concerns the subsidiary’s conduct between 1998 and 2014; in 2015 Athenian Brewery was already fined by the Greek competition authority. » Więcej na t-online.de

W 2026 roku Heineken wypłaciła już 1,92 € dywidend. Ostatnia wypłata nastąpiła w sierpień.

Dane finansowe spółki

W ostatnim kwartale Heineken osiągnęła przychody w wysokości 14,84 mld € i zysk netto w wysokości 1,13 mld €
(EUR) czerwiec 2026
YoY
Przychody 14,84 mld -
Zysk brutto 1,61 mld -
Zysk netto 1,13 mld -
EBITDA 2,81 mld -

Dane fundamentalne

Wskaźnik Wartość
Kapitalizacja rynkowa
46,8 mld €
Liczba akcji
552,38 mln
Maksimum/minimum z 52 tygodni
84,80 € - 63,90 €
Stopa dywidendy
2,26%
Dywidendy TTM
1,92 €
Beta
0,52
C/Z (PE Ratio)
20,71
PEG (PEG Ratio)
0,35
C/WK (PB Ratio)
2,43
C/S (PS Ratio)
1,28

Profil spółki

Heineken N.V. zajmuje się warzeniem i sprzedażą piwa oraz cydru. Oferuje również napoje bezalkoholowe i wodę. Swoje piwa oferuje pod markami Heineken, Amstel, Desperados, Sol, Tiger, Birra Moretti, Affligem, Lagunitas i Mort Subite, a także pod różnymi innymi markami regionalnymi i lokalnymi; cydr zaś pod markami Strongbow Apple Ciders, Orchard Thieves, Follow The Fox, Cidrerie Stassen, Bulmers, Old Mout i Blind Pig. Firma dostarcza swoje produkty detalistom, barom, pubom, hotelom i restauracjom w Europie, Ameryce, Afryce, na Bliskim Wschodzie, we Wschodniej Europie oraz na rynkach Azji i Pacyfiku. Firma została założona w 1864 roku i ma siedzibę w Amsterdamie w Holandii. Heineken N.V. jest spółką zależną Heineken Holding N.V.

Nazwa
Heineken
CEO
Rafa de Oliveira
Siedziba Amsterdam, nh
Holandia
Strona internetowa
Sektor
Dobra podstawowe
Branża
Napoje
Debiut giełdowy
29.03.1995
Pracownicy 85 000

Symbole giełdowe

Giełda Symbol
XETRA
HNK1.DE
Pnk
HINKF
Euronext
HEIA.AS
SIX
HEI.SW
Amsterdam
HEIA.AS
Frankfurt
HNK1.F
Düsseldorf
HNK1.DU
Hamburg
HNK1.HM
London
0O26.L
München
HNK1.MU
Wien
HEIA.VI
🍪

Parqet  używa plików cookie. Dowiedz się więcej